A Catalano, D Iacopetta, J Ceramella, ACD Maio… - Foods, 2022 - mdpi.com
The beginning of the end or the end of the beginning? After two years mastered by coronavirus disease 19 (COVID-19) pandemic, we are now witnessing a turnaround. The …
This review aims to evaluate the efficacy of any vitamin administration (s) in preventing and managing COVID-19 and/or long-COVID. Databases were searched up to May 2023 to …
Background Ascorbic acid (ASC; vitamin C) is a weak chromophore, so its presence cannot be determined directly by spectrophotometry. Objective This work aims to develop and …
Sandeep, R Subba, AC Mondal - Molecular Neurobiology, 2024 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which was proclaimed a pandemic by the World Health …
K Grudlewska-Buda, N Wiktorczyk-Kapischke… - Antioxidants, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading worldwide. For this reason, new treatment methods are constantly being researched …
S Sokary, A Ouagueni, V Ganji - Metabolites, 2022 - mdpi.com
Current evidence suggests that ascorbic acid improves the host's immune system and, therefore, may play a role in reducing the severity of infectious diseases. Coronavirus …
Y Yu, L Qiu - Frontiers in Medicine, 2024 - frontiersin.org
Acute respiratory distress syndrome (ARDS) is a complex and life-threatening disease characterized by severe respiratory failure. The lethality of ARDS remains alarmingly high …
EA Yılmaz, Ö Özdemir - Sakarya Tıp Dergisi, 2022 - dergipark.org.tr
Aralık 2019'da Çin'de başlayan SARS-CoV 2 enfeksiyonu olarak bilinen Coronavirüs pandemisi Dünya Sağlık Örgütü tarafından duyuruldu. Virüsü ile enfekte olan kişinin …
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died …